BRM.V - Biorem Inc


#1

Biorem est une compagnie environnemental biotechnologique. Elle conçois, manufacture et distribue des systèmes de contrôle des émissions air à haut rendement pour éliminé les odeurs, les composés organiques volatiles et les polluants atmosphériques dangereux. Les systèmes qu’elles fabriquent sont utilisés dans les usines de traitements des eaux et plusieurs autres applications industrielles que vous pouvez voir sur son [sites web][1]

Pourquoi est-il intéressant, lors de son dernier résultats financier, premier quart 2015, Biorem a déclaré des profits de $528,000 [Biorem earns $528,000 in Q1 2015][2]
le nombre d’actions émise par Biorem est tres bas soit 12,989,064
Présentement sont backlog est en croissance et les futurs bilans financier risques de suivre cette progression.

Le prix de l’action au 25 juin 2015 est de $0.29 voici la charte ci dessous


[1]: http://www.biorem.biz/
[2]: http://www.stockwatch.com/News/Item.aspx?bid=Z-C%3ABRM-2284500&symbol=BRM&region=C


#2

Le marché ne semble pas tellement apprécier les bons résultats du dernier trimestre!

Les investisseurs sont probablement encore frileux quant à la fluctuation des résultats d’un trimestre à l’autre.


#3

Le prix de l’action a quand même pratiquement doublé de $0.19 à $0.37. suite a l’annonce des résultats. il semble se formé une base au alentour de $0.28. je crois que la compagnie est en progression et n’était pas très bien suivi dans le passé. Le prochain trimestre devrait être bon , Il y avait 4.5 million en backlog et le dernier communiquer indique encore plusieurs commandes dans le pipeline. Je crois que cette compagnie mérite d’être suivi et que le prochain trimestre nous donneras une bonne indication de sa valeur.
P.S. sur le dernier communiquer le nombre actions en circulation est de 13,086,240


#4

Vidéo traduit en français sur Biorem présenté par Exportation et développement Canada (EDC)


#5

Voici les points positifs du dernier rapport de gestion de Biorem.

Key events of note in Q1 2015 include the following:

  • Revenues for the quarter increased by 18% over previous quarter to $4.7 million
  • Earnings for the quarter were $528,000 representing $0.04 per share
  • Order bookings for the quarter were $4.5 million
  • Order backlog at the end of the quarter stood at $14.7 million
  • Working capital increased to $1.4 million at March 31, 2015 compared
    to $584,000 on December 31, 2014 and ($86,000) on March 31, 2014
  • On March 31, 2015 the Company made a repayment of $200,000 against
    the outstanding balance of the 12.75% debenture
  • On May 5, 2015 the holders of $659,000 of convertible debenture
    extended the maturity date to August 16, 2016

Outlook
Strong booking activity continued from the last quarter of 2014 into the first quarter of 2015. This has enabled our backlog to increase significantly and provides good indication that 2015 will see the Corporation return to profitability. The key factors supporting this observation are a healthy backlog, lean organizational structure and efficient management processes to enable profitable project execution.
Gross margins on projects have been higher than historical numbers for the first quarter through the implementation of improved management processes started in 2014, and are expected to be maintained for the rest of the fiscal year.


#6

Le titre vient de bondir de 30%


#7

J’aurais aimé que Derek Webb détienne plus d’actions


#8

Le titre a monté jusqu’à $0.35 et a fini la journée a $0.315. Comme on peut voir sur la charte ci-dessous, BRM-V a eu un très bon support a 0.27 dans un mouvement de coté qui dure maintenant depuis environ 3 mois. depuis deux jours, il semble avoir plus d’activité sur le titre. L’an passé, les résultats trimestriel était le 22 août, donc devrait être dévoilé d’ici deux semaines.


#9

vue sur ce site…bullmarketrun.com
Biorem Inc. (BRM, TSX-V) Update

A situation that intrigues us, technically and fundamentally, is Biorem Inc. (BRM, TSX-V) which has only 13 million shares outstanding and reported revenues of nearly $5 million for Q1 and quarterly profit of $528,000…

Biorem is an environmental biotechnology company that designs, manufactures and distributes a comprehensive line of high-efficiency air emissions control systems used to eliminate odors, volatile organic compounds and hazardous air pollutants…

In mid-June, the company announced it had received several new orders totaling $2.5-million…the orders are for air emission abatement projects in North America, the Middle East and Asia…

“These recent orders are a reflection of our customers’ desires for reliability and the ability to achieve stringent performance targets,” said Derek S. Webb, President and CEO. “Each of these orders are from repeat customers who are accustomed to having their projects successfully completed on time and on budget. These projects are in the semiconductor, petrochemical, as well as the food and beverage sectors, and represent a cross-section of the potential applications where our advanced biological solutions can be effectively applied.”

Technically, what’s interesting about BRM is the fact that it’s very close to pushing through a downtrend line that has been in place for several years as shown in this 10-year monthly chart…all aspects of this chart are encouraging…BRM closed at 30.5 cents yesterday…


#10

Solide résultats: BIOREM Reports $718,000 Net Earnings for the Second Quarter

Divulgation: Pas de position.


#11

Plusieurs compagnie dans le venture offrent de solides résultats et sont sous-évalués, Biorem en est une, plusieurs investisseurs mettent leurs argents dans des titres qui sont presqu’en faillite au lieu de choisir des titres qui offrent des bon résultats.


#12

bien d’accord avec toi midard concernant de l’engouement pour des titres en faillites ou presque lorsqu’il y a plein de titres avec de l’argent en banque et qui sont profitables… je suis in depuis 2-3 mois et patient avant de vendre. Regarde EUO, c’était un peu le meme genre d’évaluation qu’il avait, et lorsqu’ils ont sorti des profits de 500k il a triplé en deux semaines. BRM pourrait bien se retrouver très rapidement en haut de 0.50$ et près du $ si le prochain trimestre est encore profitable.

Dans le même genre, je suis in aussi dans STC.V, eux les profits sont un peu plus au environ de 300k$/trimestre mais a un market cap de 6.5 M$ avec un working capital de 6.1M$ donc la cie est profitable et se transige pratiquement a sa valeur en argent. Je vais faire une recherche sur le site si quelqu’un en parle… car je suis nouvellement arrivé.


#13

Le site Bullmarketrun.com fait un suivi sur Biorem, voici le résumé,

Biorem Inc. (BRM, TSX-V) Update

Is there value on the Venture right now?…absolutely, though follow the 80/20 rule – only 20% of the companies are really worth considering, the other 80% are junk…within that 20%, you can narrow things down even more to the very best opportunities…

Our last update on Biorem was August 7 when it was trading around 30 cents…this morning the company reported its Q2 financial results, showing net earnings for the quarter of $718,000 or 5 per share (undiluted)…this brings net earnings for the 1st half of the fiscal year (January 1 to June 30) to $1.25 million or 9 cents per share (vs. a net loss of $1.36 million for the 1st 6 months of 2014)…

Biorem’s revenues for Q2 were $4.7 million, a 91% increase over the $2.2 million in revenue recorded during the same period last year and consistent with the $4.7 million recorded in Q1…year-to-date revenue has totaled $9.4 million, a $5 million or 112% jump in revenue over the 1st half of 2014…the revenue increase came from each of the geographic markets in which Biorem operates…

Biorem, which has only 13 million shares outstanding, is an environmental biotechnology company that designs, manufactures and distributes a comprehensive line of high-efficiency air emissions control systems used to eliminate odors, volatile organic compounds and hazardous air pollutants…

“The company is well positioned to deliver consistent results for the second half of the year,” said Derek S. Webb, President and CEO. “Overall booking activity in the near term is expected to be consistent with the previous two quarters. We expect continued growth in our overseas markets as new regulatory structures are implemented to curb the release of greenhouse gas emissions and communities demand a higher quality of life free of nuisance conditions.”

Technically, what’s interesting about BRM is the fact that it’s very close to confirming a breakout above a downtrend line that has been in place for several years as shown in this 10-year monthly chart…all aspects of this chart are encouraging…this company is making money, and that’s a rarity on the Venture…


#14

Journée incroyable pour BRM avec une bonne nouvelle.

Biorem wins $5.7-million in new orders

2015-08-31 15:10 ET - News Release

Mr. Derek Webb reports

BIOREM ANNOUNCES ORDERS TOTALLING $5.7 MILLION

Biorem Inc. has won several new orders totalling $5.7-million. The orders are for air emission abatement projects in North America.

“Of particular note is a large order for a municipality in the southern [United States], where our equipment will be replacing a competitor’s system that failed to meet the customer’s requirements. This demonstrates the value our customers see in our engineered solutions,” said Derek S. Webb, president and chief executive officer of Biorem.

“With Biorem set to celebrate its 25th year anniversary in the fall and over 1,000 installations globally, Biorem continues to be the industry leader in innovation, reliability and performance. These recent orders are affirmation of the current market demand for a reliable partner in achieving regulatory compliance for odours and air emissions at municipal and industrial facilities,” concluded Mr. Webb.


#15

Très belle charte…


#16

Tres beau call @midard, ce sont des gens comme toi qui rendent ce forum intéressant!

Merci de partage le résultat de tes recherches!


#17

Il y a eu un update sur Biorem sur le site Bullmarketrun.com, on peut voir sur la charte que le titre est entrain de de se stabiliser au alentour de $0.50 le prochain niveau de résistance est à $0.75 voici le résumé

Biorem Inc. (BRM, TSX-V) Update

Biorem Inc. (BRM, TSX-V) is up 40% since we introduced it to our readers a few months ago around 30 cents…there’s nothing like old-fashioned earnings momentum (a rarity on the Venture) to drive a stock price, but that’s what’s happening with Biorem…it shot up from 32.5 cents August 27 to a multi-year high of 65 cents just 3 trading sessions later on the release of Q2 financial results…yes, a double in only 3 trading sessions…not unexpectedly, it has given back some of those gains to unwind temporarily overbought conditions, but support is strong in the vicinity of 50 cents and we can’t help but believe the potential for BRM is exceedingly bright given how its business is expanding and in a profitable fashion…

Biorem reported net earnings for Q2 of $718,000 or 5 cents per share (undiluted)…this brings net earnings for the 1st half of the fiscal year (January 1 to June 30) to $1.25 million or 9 cents per share (vs. a net loss of $1.36 million for the 1st 6 months of 2014)…

Biorem’s revenues for Q2 were $4.7 million, a 91% increase over the $2.2 million in revenue recorded during the same period last year and consistent with the $4.7 million recorded in Q1…year-to-date revenue has totaled $9.4 million, a $5 million or 112% jump in revenue over the 1st half of 2014…this increase came from each of the geographic markets in which Biorem operates (the U.S. represents its largest single market)…the value of the company’s order backlog as of June 30 was $14.4 million…management estimates that more than 50% of the order backlog will be converted into revenue by year-end (MD&A)…

In addition, on August 31, BRM reported that it has won several new orders totaling $5.7 million for air emission abatement projects in North America, including a large order from a municipality in the southern U.S. where the company’s equipment will be replacing a competitor’s system that failed to meet the customer’s requirements…

With only 13 million shares currently outstanding, BRM is an environmental biotechnology company that designs, manufactures and distributes a comprehensive line of high-efficiency air emissions control systems used to eliminate odors, volatile organic compounds and hazardous air pollutants…

Technically, BRM is on a major new uptrend as confirmed by important breakouts on this 10-year monthly chart…


#18

Entrevue avec Derek Webb sur Midas letter


#19

Petit bémol ici, beaucoup beaucoup de vente des insiders, on dirait qu’ils on peu foi dans leur compagnie…


#20

Petit bémol concernant ces ventes d’insider.

Ces ventes proviennent de warrant entre 10 et 20 cent, à ce niveau de profit et surtout s’il n’avait pas d’argent pour les excercer et les conserver, j’aurais fait la même chose, que je croit ou non en ma compagnie. Surtout si en plus ces warrants allaient expirer bientot (je n’ai pas fouillé à ce niveau)

By the way, Je ne connais pas la compagnie, ni la situation de ces “insider”, ce n’est qu’un hypothèse plausible.